Short-term diabetes attenuates left ventricular dysfunction and mortality rates after myocardial infarction in rodents

Clinics

Volumn 66, Issue 8, 2011, Pages 1437-1442

  Rodrigues, Bruno ^a,b   Figueroa, Diego Mendrot Taboas ^b   Fang, Jiao ^b   Rosa, Kaleizu Teodoro ^b   Llesuy, Suzana ^c   de Angelis, Kátia ^d   Irigoyen, Maria Cláudia ^b  

^a SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Nove de Julho University   (Brazil)

Author keywords

Diabetes; Mortality Rate; Myocardial Infarction; Oxidative Stress; Ventricular Function

Indexed keywords

CATALASE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; EXPERIMENTAL DIABETES MELLITUS; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HYPERGLYCEMIA; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SURVIVAL RATE; WISTAR RAT;

ANIMALS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; MALE; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN; SURVIVAL RATE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80052694912     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000800022     Document Type: Article

References (30)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53, doi: 10.2337/diacare.27.5.1047.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34, doi: 10.1056/NEJM199807233390404.
3. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997;34:113-20, doi: 10.1016/S0008-6363(97)00037-0.
4. Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A, et al. Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia? Basic Res Cardiol. 2001;96:160-8, doi: 10.1007/s003950170066.
5. Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, et al. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia. 2004;47:325-30, doi: 10.1007/s00125-003-1311-5.
6. Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, et al. Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail. 2010;12:659-67, doi: 10.1093/eurjhf/hfq053.
7. Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhöffer A, et al. Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem. 2000;210:143-51, doi: 10.1023/A:1007129708262.
8. Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C, et al. Is hyperglycemia bad for the heart during acute ischemia? J Thorac Cardiovasc Surg. 2010;140:1345-52, doi: 10.1016/j.jtcvs.2010.05.009.
9. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol. 1996;148:291-300.
10. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 199617;347:444-5, doi: 10.1016/S0140-6736(96)90013-6.
11. Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, et al. Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J. 2011;32:904-12, doi: 10.1093/eurheartj/ehq244.
12. Wichi R, Malfitano C, Rosa K, De Souza SB, Salemi V, Mostarda C, et al. Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol. 2007;26;6:14, doi: 10.1186/1475-2840-6-14.
13. Llesuy SF, Milei J, Molina H, Boveris A, Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 49-epiadrimicin in mice. Tumori. 1985;71:241-9.
14. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-10, doi: 10.1016/S0076-6879(78)52032-6.
15. De Angelis K, Cestari IA, Barp J, Dall'Ago P, Fernandes TG, de Bittencourt PI, et al. Oxidative stress in the latissimus dorsi muscle of diabetic rats. Braz J Med Biol Res. 2000;33:1363-8, doi: 10.1590/S0100-879X2000001100016.
16. Aebi H. Catalase in vitro. Meth Enzymol. 1984;105:121-6, doi: 10.1016/ S0076-6879(84)05016-3.
17. Flores LJ, Figueroa D, Sanches IC, Jorge L, Irigoyen MC, Rodrigues B, et al. Effects of exercise training on autonomic dysfunction management in an experimental model of menopause and myocardial infarction. Menopause. 2010;17:712-7.
18. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DCJr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-59, doi: 10.1056/NEJMoa0802743.
19. The ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-72, doi: 10.1056/NEJMicm066227.
20. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-39, doi: 10.1056/NEJMoa0808431.
21. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. 2000;101:2090-6.
22. King LM, Opie LH. Glucose and glycogen utilisation in myocardial ischemia changes in metabolism and consequences for the myocyte. Mol Cell Biochem. 1998;180:3-26, doi: 10.1023/A:1006870419309.
23. Ma G, Al-Shabrawey M, Johnson JA, Datar R, Tawfik HE, Guo D, et al. Protection against myocardial ischemia/reperfusion injury by short term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling. Naunyn Schmiedebergs Arch Pharmacol. 2006;373:415-27, doi: 10.1007/s00210-006-0102-1.
24. Ravingerova T, Neckar J, Kolar F. Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes. Mol Cell Biochem. 2003;249:167-74, doi: 10.1023/A:1024751109196.
25. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z. Contradictory effects of short-and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol. 2004;76:57-65, doi:10.1016/j.yexmp.2003.08.003.
26. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation. 1997;95:320-3.
27. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-51, doi: 10.1016/0092-8674(93)80066-N.
28. Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Atiox Redox Signal. 2003;5:731-40, doi: 10.1089/152308603770380034.
29. Maritim AC, Sanders RA, Watkins JB, 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24-38, doi: 10.1002/jbt.10058.
30. Christie KN. Catalase in skeletal muscle fibers. J Histochem Cytochem. 1979;27:814-9, doi: 10.1177/27.4.376691.